List of insiders holdings for CELGENE CORP:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| HUGIN ROBERT J see remarks | 2018-01-31 16:39:58 | 1,015,106 10,241 | 1,025,347 | Form 5 |
| JACKSON JOHN W Director | 2006-11-22 16:17:18 | 978,958 6264 | 985,222 | Form 4 |
| BARER SOL J Director | 2011-01-14 16:35:57 | 692,192 61,281 | 753,473 | Form 4 |
| MORGAN RICHARD C E Director | 2008-08-08 16:35:28 | 453,993 0 | 453,993 | Form 4 |
| BROUWER AART See Remarks | 2011-01-04 16:08:30 | 102,778 0 | 102,778 | Form 4 |
| KAPLAN GILLA Director | 2018-05-21 16:15:15 | 76,301 0 | 76,301 | Form 4 |
| KARSEN PERRY A see remarks | 2016-02-02 16:49:34 | 65,432 1639 | 67,071 | Form 5 |
| Moriarty Thomas M see remarks | 2012-06-05 16:25:57 | 53,333 0 | 53,333 | Form 4 |
| Daniel Thomas O see remarks | 2016-02-02 16:47:04 | 49,972 3200 | 53,172 | Form 5 |
| Smith Scott Andrew See Remarks | 2018-02-20 17:03:46 | 49,419 2788 | 52,207 | Form 4 |
| DRAKE RODMAN L Director | 2014-06-16 18:54:15 | 30,315 0 | 30,315 | Form 4 |
| KELLOGG PETER N SEE REMARKS | 2018-08-01 16:05:22 | 20,285 0 | 20,285 | Form 4 |
| STEIN LAWRENCE V See Remarks | 2015-05-15 16:30:08 | 19,133 519 | 19,652 | Form 4 |
| FOUSE JACQUALYN A see remarks | 2017-02-16 17:14:06 | 16,322 0 | 16,322 | Form 4 |
| Masoudi Gerald SEE REMARKS | 2018-06-05 16:09:41 | 13,281 417 | 13,698 | Form 4 |
| PEHL MICHAEL F. See remarks | 2017-08-01 16:56:43 | 11,755 0 | 11,755 | Form 4 |
| GRYSKA DAVID W Chief Financial Officer | 2010-07-15 16:47:16 | 11,675 0 | 11,675 | Form 4 |
| Burton Graham See Remarks | 2012-02-01 16:58:55 | 10000 0 | 10000 | Form 4 |
| ROBB WALTER L Director | 2011-06-17 18:12:06 | 6109 0 | 6109 | Form 4 |
| Van Hoek Andre Controller and CAO | 2011-11-01 15:03:46 | 5000 0 | 5000 | Form 4 |
| BOWMAN JACK L Director | 2007-09-18 16:20:11 | 4625 0 | 4625 | Form 4 |
| REICIN ALISE PRES., GLOBAL CLINICAL DEV. | 2019-11-22 07:31:03 | 0 0 | 0 | Form 4 |
| Haller Julia A Director | 2019-11-22 07:30:54 | 0 0 | 0 | Form 4 |
| Biller Jonathan EVP AND GENERAL COUNSEL | 2019-11-22 07:31:12 | 0 0 | 0 | Form 4 |
| LOUGHLIN JAMES J Director | 2019-11-22 07:30:59 | 0 0 | 0 | Form 4 |
| BARKER RICHARD W Director | 2019-11-22 07:30:15 | 0 0 | 0 | Form 4 |
| Curran Terrie PRES., GLBL INFLAM. AND IMMUN. | 2019-11-22 07:31:21 | 0 0 | 0 | Form 4 |
| Elkins David V EVP, CHIEF FINANCIAL OFFICER | 2019-11-22 07:31:25 | 0 0 | 0 | Form 4 |
| Alles Mark J CEO, CHAIRMAN OF BOARD | 2019-11-22 07:31:34 | 0 0 | 0 | Form 4 |
| AHMED NADIM PRES., GLOBAL HEM. AND ONC. | 2019-11-22 07:31:43 | 0 0 | 0 | Form 4 |
| VESSEY RUPERT PRES., RESEARCH AND EARLY DEV. | 2019-11-22 07:31:48 | 0 0 | 0 | Form 4 |
| Friedman Michael A Director | 2019-11-22 07:30:50 | 0 0 | 0 | Form 4 |
| COX CARRIE SMITH Director | 2019-11-22 07:30:46 | 0 0 | 0 | Form 4 |
| MARIO ERNEST Director | 2019-11-22 07:30:41 | 0 0 | 0 | Form 4 |
| CASEY MICHAEL D Director | 2019-11-22 07:30:37 | 0 0 | 0 | Form 4 |
| BONNEY MICHAEL W Director | 2019-11-22 07:30:33 | 0 0 | 0 | Form 4 |
| Hall Patricia Hemingway Director | 2019-11-22 07:30:28 | 0 0 | 0 | Form 4 |
| WEILAND JOHN H Director | 2019-11-22 07:30:24 | 0 0 | 0 | Form 4 |
| Bishop Hans Edgar Director | 2019-11-22 07:30:19 | 0 0 | 0 | Form 4 |
| CARY FRANK T Director | 2006-02-13 16:10:34 | 0 0 | 0 | Form 5 |
| HAYES ARTHUR H JR Director | 2010-02-11 17:00:45 | 0 0 | 0 | Form 4 |